Clinical Trials Insight: 700028409
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2008
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- Sponsors MAP Pharmaceuticals
- 07 Apr 2008 Status changed from recruiting to completed according to a MAP Pharmaceuticals media release.
- 07 Apr 2008 Positive results were reported in a MAP Pharmaceuticals media release.
- 13 Nov 2007 New trial record.